Biotech

All Articles

Arch closes $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund from Bain Funds Lifestyle Sciences, Arc Project Allies is showing...

Orion to make use of Aitia's 'electronic doubles' to find new cancer medications

.Finnish biotech Orion has snooped prospective in Aitia's "electronic double" tech to develop new ca...

Windtree's surprise med brings up high blood pressure in most up-to-date phase 2 succeed

.While Windtree Therapeutics has actually battled to grow the monetary roots needed to endure, a pha...

2 cancer cells biotechs combine, creating international impact

.OncoC4 is taking AcroImmune-- as well as its own in-house medical production functionalities-- unde...

Amgen files very first phase 3 win for $400M chronic eczema medication

.Amgen has actually shared (PDF) the first period 3 data on its own $400 thousand chronic eczema med...

Biogen, UCB file phase 3 lupus win after stopping working earlier trial

.Biogen and UCB's bet one's bottom dollar improving into stage 3 on the back of a broken research se...

Aptadir really hopes brand-new RNA inhibitors can easily turn around difficult cancers

.Italian biotech Aptadir Rehabs has actually released along with the pledge that its pipeline of pre...

Wave surfs DMD results to regulators' doors, sending out stock up

.Surge Life Sciences has actually fulfilled its own target in a Duchenne muscle dystrophy (DMD) rese...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupy...

Achilles drips tissue therapy course, prepares for cutbacks after missing 'commercial practicality' goals

.Achilles Rehabs has actually wrecked its technique. The English biotech is quiting working on its c...